Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. 1994

M Warny, and J P Vaerman, and V Avesani, and M Delmée
Microbiology Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

This study investigated whether differences in fecal and serum antitoxin A antibody levels may account for the duration of Clostridium difficile-associated diarrhea (CDAD) and the occurrence of relapses. By an enzyme linked-immunosorbent assay, we tested 40 patients with CDAD including 25 patients without immunodeficiency and 15 patients receiving antineoplastic drugs. Two hundred eighty serum samples and 80 normal stool samples were investigated as controls. In nonimmunocompromised patients, serum immunoglobulin (IgG) and fecal IgA antitoxin A antibody titers were significantly higher in patients who suffered a single episode (n = 21) than in those with relapsing CDAD (n = 4) whose titers were at control levels. Of these 25 patients, eight suffered from diarrhea which lasted for more than 2 weeks. These patients had significantly lower serum- and feces-specific antibody levels than the others who presented symptoms of shorter duration. In cytostatic-treated patients, antitoxin A antibody levels were similar to controls, but relapses occurred in a single case. These data suggest an association between a defective humoral response to toxin A and a more severe form of C. difficile infection. They also indicate that other host-related factors control the severity of CDAD and remain to be elucidated.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004761 Enterocolitis, Pseudomembranous An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization. Antibiotic-Associated Colitis,Clostridium Enterocolitis,Colitis, Pseudomembranous,Enteritis, Pseudomembranous,Pseudomembranous Colitis,Pseudomembranous Enteritis,Pseudomembranous Enterocolitis,Antibiotic Associated Colitis,Colitis, Antibiotic-Associated
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females

Related Publications

M Warny, and J P Vaerman, and V Avesani, and M Delmée
July 2004, FEMS immunology and medical microbiology,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
March 2003, Infection and immunity,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
October 1991, Infection and immunity,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
January 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
July 2017, Expert review of gastroenterology & hepatology,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
January 2001, Lancet (London, England),
M Warny, and J P Vaerman, and V Avesani, and M Delmée
January 1992, Gastroenterology,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
February 2021, Anaerobe,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
December 2010, Nature reviews. Gastroenterology & hepatology,
M Warny, and J P Vaerman, and V Avesani, and M Delmée
March 2016, JAMA internal medicine,
Copied contents to your clipboard!